Epigenetics clinical research

Expert-led webinar sessions on genomics, epigenomics, and pathology

See what genomics alone can miss and how the methylome and epigenome can reveal hidden biology in complex disease

The future of epigenetics

In this short introduction Dr Steve Barnard discusses how genomics, epigenomics, and multiomics deliver a more complete view of biology.

Series overview

Gain practical, evidence-based perspectives on how genomics, epigenomics, and multiomics can reveal a more complete view of biology. Explore expert-led discussions of real-world applications across three areas of clinical research:

Germline and somatic research

Explore genomic approaches to complex cancers (CNS tumors, hematologic malignancies, sarcomas, CUP, MRD), as well as rare, developmental, metabolic, immune, and neurological disorders across pediatric and adult clinical research.

Methylation biomarker profiling

Identify and apply methylation signatures to advance disease classification and improve research accuracy across tissue and liquid-biopsy approaches for clinical research.

Multiomic and AI-driven insight

Integrate multiomic data and AI-enabled approaches to enhance laboratory research workflows and support more informed interpretation.

Upcoming webinars

Join us live and bring your questions

Nov 19, 2026 at 7:00 AM PT

Exploring cfDNA genomic and epigenomic profiling for oncology biomarker discovery research

Discover how integrated cfDNA genomic and epigenomic profiling from a single liquid biopsy sample can expand oncology biomarker discovery. Learn how this approach is being applied to neuroendocrine tumor research to support deeper molecular insights.

Register to watch on-demand

Rare disease research and CNS tumors

Unlock the power of epigenetics in precision medicine research. In this webinar, Bekim Sadikovic and Helge Lubenow demonstrate how methylation signatures and 5-base sequencing are accelerating rare disease research, clarifying ambiguous results, and improving tumor classification.

Cancer of unknown primary (CUP)

Discover how liquid biopsy and multiomic analysis are transforming translational cancer research. In this webinar, Alexandra Clipson reviews how DNA methylation, fragmentomics, and 5-base sequencing can help identify cancers of unknown primary.

DNA methylation epimutations in acute myeloid leukemia

In this webinar, Dr David Spencer, MD, PhD, explores how genomic and epigenomic biomarkers are advancing AML translational research. Learn about clonal mutations, DNA methylation epimutations, and emerging assays for measuring molecular changes in AML.

Quantification of biological aging

Dr Daniel Belsky, PhD, examines the science behind DNA methylation-based aging clocks and their potential to provide sensitive biological measurements for advancing health research in this webinar.

Multiomic profiling of plasma circulating tumor DNA in pediatric cancer research

In this webinar, Carrie Cibulskis explores how advances in methylation analysis and genomic profiling are helping researchers use liquid biopsies to better detect and classify rare pediatric kidney cancers.

Go deeper into methylation and multiomics

Deepen your understanding with resources that connect methylation and multiomic research to the technologies, analysis tools, and innovations enabling deeper biological insights.

Never miss a session

Subscribe to get new live dates and on-demand recordings delivered to your inbox, and download presentation slides from completed sessions.